BioRad Laboratories, headquartered in Hercules, California, develops specialty chemicals and offers products for biochemical, pharmaceutical, and life science research, employing 8,030 people. It operates in Life Science and Clinical Diagnostics segments, serving various laboratory markets.
BIO has been in the news recently: Bio-Rad Laboratories, Inc. plans to acquire Stilla Technologies by the end of Q3 2025 to enhance its digital PCR offerings, with an expected revenue impact of $2.6 billion. In Q4 2024, Bio-Rad reported revenue of $667.5 million, reflecting a 2% decrease from the previous year as the company emphasizes transformation and margin improvement.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.